PKP2 and arrhythmogenic right ventricular cardiomyopathy: During the in‐depth exploration of Pkp2 deficiency in the pathogenesis of ARVC, we uncovered novel molecular mechanisms that may be directly regulated by PKP2 and contribute to disease progression.